Idaho Sci-Tech Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Sci-Tech Network.

Press releases published on November 9, 2026

20 minutes ago

Notice of Extraordinary General Meeting of Shareholders of Kaspi.kz

Indeterminate GlobeNewswire

23 minutes ago

Kamada Reports Record-High First Nine Months 2026 Financial Results; Increases 2026 Annual Guidance and Projects Double-Digit Growth in Revenues and Profitability in 2027

Indeterminate GlobeNewswire

25 minutes ago

Immunocore to present at upcoming investor conferences

Indeterminate GlobeNewswire

25 minutes ago

Octave introduces Attune Facilities, bringing AI-powered facilities management and spatial intelligence to complex multi-site operations

Indeterminate GlobeNewswire

25 minutes ago

TRIDENT post-hoc analysis of low-dose triple combination therapy by kidney function in people with prior intracerebral hemorrhage presented at American Heart Association’s Scientific Sessions 2026

Indeterminate GlobeNewswire

25 minutes ago

GT Biopharma Oral Presentation at the SITC 2026 Annual Meeting

Indeterminate GlobeNewswire

25 minutes ago

NovaBridge Biosciences to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

25 minutes ago

Aura Biosciences Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

25 minutes ago

Aquestive Therapeutics to Present at the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

25 minutes ago

Zenas BioPharma to Present at the Jefferies London Global Healthcare Conference

Indeterminate GlobeNewswire

25 minutes ago

Adagene Announces Completion of Enrollment in Randomized Dose Optimization Phase 2 Trial of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer

Indeterminate GlobeNewswire

25 minutes ago

Allegacy Financial Selects Kobalt Labs to Replace Legacy Systems and Unify TPRM, ERM, and Compliance on an AI-Native Platform

Indeterminate GlobeNewswire

25 minutes ago

Marengo Presents Interim Phase 2 STARt-002 Results for First-in-Class Selective T-Cell Agonist Invikafusp Alfa Plus Sacituzumab Govitecan Across Two Metastatic Breast Cancer Cohorts in Oral Presentation at SITC 2026

Indeterminate GlobeNewswire

25 minutes ago

Tonix Pharmaceuticals Reports Third Quarter 2026 Financial Results and Operational Highlights

Indeterminate GlobeNewswire

25 minutes ago

Hemab Therapeutics Initiates SOLARA, a Pivotal Phase 3 Trial of Sutacimig in Glanzmann Thrombasthenia

Indeterminate GlobeNewswire

25 minutes ago

Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2026 on the Potential of MRT-8102 in Gout

Indeterminate GlobeNewswire

25 minutes ago

Agility to Attend Upcoming Investor Conferences

Indeterminate GlobeNewswire

25 minutes ago

Editas Medicine Announces Third Quarter 2026 Results and Business Updates

Indeterminate GlobeNewswire

25 minutes ago

Nkarta Announces Initial Clinical Data for NKX019 in Myositis and Systemic Sclerosis at ACR Convergence

Indeterminate GlobeNewswire

25 minutes ago

Roivant Reports Financial Results for the Second Quarter Ended September 30, 2026, and Provides Business Update

Indeterminate GlobeNewswire